Human Osteopontin (OPN) Quantikine SixPak (6 Plates)

• Supplier: R&D Systems
• Catalog: SOST00
• Category: ELISA Kit
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (50 µL), EDTA Plasma (10 µL), Heparin Plasma (10 µL), Urine (50 µL), Human Milk (50 µL)
• Sensitivity: 0.024 ng/mL
• Range: 0.312 - 20 ng/mL (Heparin Plasma, Cell Culture Supernates, Human Milk, EDTA Plasma, Urine)
• Format: 96-well strip plate
• Description: The Quantikine Human Osteopontin Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human Osteopontin in cell culture supernates, plasma, urine, and human milk
• Gene: SPP1

Product References

Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial - Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial

Yamaguchi Y, Shao Z, Sharif S, Du XY, Myles T, Merchant M, Harsh G, Glantz M, Recht L, Morser J, Leung LL. J Biol Chem. 2013 Feb 1;288(5):3097-111.

Osteopontin is a prognostic biomarker in non-small cell lung cancer. - Osteopontin is a prognostic biomarker in non-small cell lung cancer.

Rud AK, Boye K, Oijordsbakken M, Lund-Iversen M, Halvorsen AR, Solberg SK, Berge G, Helland A, Brustugun OT, Maelandsmo GM. BMC Cancer. 2013 Nov 11;13:540.

Osteopontin is a prognostic factor for survival of acute myeloid leukemia - Osteopontin is a prognostic factor for survival of acute myeloid leukemia

Liersch R, Gerss J, Schliemann C, Bayer M, Schwoppe C, Biermann C, Appelmann I, Kessler T, Lowenberg B, Buchner T, Hiddemann W, Muller-Tidow C, Berdel WE, Mesters R. Blood. 2012 May 31;119(22):5215-20.

A multi-analyte assay for the non-invasive detection of bladder cancer. - A multi-analyte assay for the non-invasive detection of bladder cancer.

Goodison S, Chang M, Dai Y, Urquidi V, Rosser CJ. PLoS One. 2012;7(10):e47469.

Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase - Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase

Sim SH, Messenger MP, Gregory WM, Wind TC, Vasudev NS, Cartledge J, Thompson D, Selby PJ, Banks RE. Br J Cancer. 2012 Sep 25;107(7):1131-7.

Plasma markers for identifying patients with metastatic melanoma. - Plasma markers for identifying patients with metastatic melanoma.

Kluger HM, Hoyt K, Bacchiocchi A, Mayer T, Kirsch J, Kluger Y, Sznol M, Ariyan S, Molinaro A, Halaban R. Clin Cancer Res. 2011 Apr 15;17(8):2417-25.

An in vivo platform for tumor biomarker assessment. - An in vivo platform for tumor biomarker assessment.

Servais EL, Suzuki K, Colovos C, Rodriguez L, Sima C, Fleisher M, Rusch VW, Sadelain M, Adusumilli PS. PLoS One. 2011;6(10):e26722.

Serum levels of beta-catenin as a potential marker for genotype 4/hepatitis - Serum levels of beta-catenin as a potential marker for genotype 4/hepatitis

Zekri AR, Bahnassy AA, Alam El-Din HM, Morsy HM, Shaarawy S, Moharram NZ, Daoud SS. Oncol Rep. 2011 Oct;26(4):825-31.

Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a - Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a

Georgiadou P, Iliodromitis EK, Kolokathis F, Varounis C, Gizas V, Mavroidis M, Capetanaki Y, Boudoulas H, Kremastinos DT. Eur J Clin Invest. 2010 Apr;40(4):288-93.

Circulating levels of osteopontin are closely related to glomerular filtration - Circulating levels of osteopontin are closely related to glomerular filtration

Lorenzen J, Kramer R, Kliem V, Bode-Boeger SM, Veldink H, Haller H, Fliser D, Kielstein JT. Eur J Clin Invest. 2010 Apr;40(4):294-300.